It’s not often that a CEO outright dismisses M&A prospects, but Moderna CEO Stéphane Bancel says the mRNA biotech has enough ...

Massachusetts-based Moderna, one of the companies at the forefront of developing a vaccine during the COVID pandemic, ...

Moderna, based in Cambridge, will lay off 10% of its workforce and expects “to be fewer than 5,000 colleagues strong” by the ...

In a note to employees on Thursday, Moderna Inc. said it was laying off about 10% of its global workforce as part of the ...

Vaccine manufacturer Moderna will lay off hundreds of employees about five years after it rose to prominence during the COVID ...

Moderna's CEO, Stéphane Bancel, stated that vaccination is an "important tool for protecting our youngest against severe disease and hospitalization." ...

Moderna’s CEO Stéphane Bancel celebrated the approval, writing, “COVID-19 continues to pose a significant potential threat to children, especially those with underlying medical conditions.

“COVID-19 continues to pose a significant potential threat to children, especially those with underlying medical conditions. Vaccination can be an important tool for protecting our youngest against ...

Vaccination can be an important tool for protecting our youngest against severe disease and hospitalization," said Stéphane Bancel, Chief Executive Officer of Moderna.